Considerations in Gene and Cell Therapy Manufacturing

James Brown, Vice President, Corporate Development, Aldevron

Video Overview

James Brown, vice president of corporate development at Aldevron, offered the conference a summary of existing gene therapy products before moving on to review in great detail the challenges associated with their manufacture and translation to the clinic, and the options Aldevron can provide to streamline that process. Finally, Dr. Brown considered the potential for independent regulation of the gene, vector and formulation components of such therapies, a prospect which could greatly improve opportunities for personalised medicine.